Resveratrol for Acanthamoeba eye infection
Part of Eyes & vision, Infections clinical trials.
This trial tests whether resveratrol, a natural substance, can help treat Acanthamoeba keratitis (a rare but serious eye infection). It also looks at a nanoparticle form that may work better. This could offer a new option for people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a painful, inflamed cornea (keratitis) or a corneal ulcer.
- Your corneal infection is caused by Acanthamoeba, not bacteria, a virus, or a fungus.
- You do not have other serious eye problems like a hole in the cornea, severe dry eye, glaucoma, or active eye inflammation.
- You have not had eye surgery or a cornea transplant before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment for people who still have eye inflammation after 1 month of standard treatment for a parasitic eye infection (acanthamoeba keratitis). It aims to find a better way to control the infection and reduce inflammation.
This trial tests a new eye drop (acoltrepon) to see if it helps people with stage 1 neurotrophic keratopathy (a condition where the cornea's nerves are damaged, causing dry eyes and vision problems) and low tear production. It aims to improve signs like corneal staining and symptoms of discomfort.
This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.
This trial tests a new eye drop called IVIEW-1201 to see if it works as well as the current standard treatment for fungal keratitis, a serious infection of the cornea. If you have a fungal eye infection confirmed by a lab test and have not used antifungal medications in the last two days, you may be able to join.
This Phase 2 trial tests a locally delivered cell-based treatment (allogeneic mesenchymal stromal cells) to help heal long-lasting damage to the eye’s clear surface (the cornea). It may help if your cornea epithelium (surface layer) won’t improve even after standard non-surgical treatments.
This study tests a new medication called Acoltremon to see if it helps dry eye symptoms over a long period. If you've had dry eye for a while and used artificial tears, this trial might be for you.
Hear when a new Corneal Ulcer Caused by Acanthamoeba trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.